神经科

订阅

MedSci主页 / 所有栏目 / 神经科

青年卒中患者取栓术后早期影像学表现

2022-08-26 韩翔 MedSci原创

脑卒中神经科神经外科青年卒中取栓术
关注

复旦大学附属华山医院

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720478, encodeId=87541e20478f6, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Sep 21 05:13:56 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033453, encodeId=de4e2033453eb, content=<a href='/topic/show?id=800638008ea' target=_blank style='color:#2F92EE;'>#取栓术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38008, encryptionId=800638008ea, topicName=取栓术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Jul 14 04:13:56 CST 2023, time=2023-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770058, encodeId=51801e70058ec, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Sun Jul 30 09:13:56 CST 2023, time=2023-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479129, encodeId=453e14e9129d6, content=<a href='/topic/show?id=b97f3800ee0' target=_blank style='color:#2F92EE;'>#取栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38007, encryptionId=b97f3800ee0, topicName=取栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99077483919, createdName=1249862am74(暂无昵称), createdTime=Thu Aug 25 04:13:56 CST 2022, time=2022-08-25, status=1, ipAttribution=)]
    2022-09-21 wangyang7969

    #卒中患者#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1720478, encodeId=87541e20478f6, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Sep 21 05:13:56 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033453, encodeId=de4e2033453eb, content=<a href='/topic/show?id=800638008ea' target=_blank style='color:#2F92EE;'>#取栓术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38008, encryptionId=800638008ea, topicName=取栓术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Jul 14 04:13:56 CST 2023, time=2023-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770058, encodeId=51801e70058ec, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Sun Jul 30 09:13:56 CST 2023, time=2023-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479129, encodeId=453e14e9129d6, content=<a href='/topic/show?id=b97f3800ee0' target=_blank style='color:#2F92EE;'>#取栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38007, encryptionId=b97f3800ee0, topicName=取栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99077483919, createdName=1249862am74(暂无昵称), createdTime=Thu Aug 25 04:13:56 CST 2022, time=2022-08-25, status=1, ipAttribution=)]
    2023-07-14 jinweidong

    #取栓术#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1720478, encodeId=87541e20478f6, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Sep 21 05:13:56 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033453, encodeId=de4e2033453eb, content=<a href='/topic/show?id=800638008ea' target=_blank style='color:#2F92EE;'>#取栓术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38008, encryptionId=800638008ea, topicName=取栓术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Jul 14 04:13:56 CST 2023, time=2023-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770058, encodeId=51801e70058ec, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Sun Jul 30 09:13:56 CST 2023, time=2023-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479129, encodeId=453e14e9129d6, content=<a href='/topic/show?id=b97f3800ee0' target=_blank style='color:#2F92EE;'>#取栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38007, encryptionId=b97f3800ee0, topicName=取栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99077483919, createdName=1249862am74(暂无昵称), createdTime=Thu Aug 25 04:13:56 CST 2022, time=2022-08-25, status=1, ipAttribution=)]
    2023-07-30 李研东

    #青年卒中#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1720478, encodeId=87541e20478f6, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Sep 21 05:13:56 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033453, encodeId=de4e2033453eb, content=<a href='/topic/show?id=800638008ea' target=_blank style='color:#2F92EE;'>#取栓术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38008, encryptionId=800638008ea, topicName=取栓术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Jul 14 04:13:56 CST 2023, time=2023-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770058, encodeId=51801e70058ec, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Sun Jul 30 09:13:56 CST 2023, time=2023-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479129, encodeId=453e14e9129d6, content=<a href='/topic/show?id=b97f3800ee0' target=_blank style='color:#2F92EE;'>#取栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38007, encryptionId=b97f3800ee0, topicName=取栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99077483919, createdName=1249862am74(暂无昵称), createdTime=Thu Aug 25 04:13:56 CST 2022, time=2022-08-25, status=1, ipAttribution=)]
    2022-08-25 1249862am74(暂无昵称)

    #取栓#

    0

相关资讯

Stroke|天坛王伊龙：生活中简单的7件事与脑小血管疾病的关系

理想的LS7评分表明心血管健康状况良好，与CSVD总负担较低有关。

空腹血糖升高，脑卒中风险高！全球疾病负担报告

终其一生，男性比女性高空腹血糖相关脑卒中发生风险更高。

卒中患者「早期康复」治疗为何如此重要？一组数据说清楚！

《2018-2021年度康复临床成果报告》发布，卒中康复亟需尽早启动治疗，不可忽视言语功能障碍和心理健康。

J Dermatolog Treat：警惕化脓性皮炎患者脑卒中的发生风险

化脓性皮炎（HS）是一种慢性炎症性皮肤病，以疼痛的结节、脓肿、窦道形成和瘢痕为特征。除了皮肤表现外，越来越多的证据表明HS与其他系统性疾病有关，包括自身免疫、内分泌、炎症和心血管疾病。

Cardiovasc Diabetol：TyG指数变化轨迹与高血压患者卒中风险的相关性

定期监测 TyG 指数可能有助于及时识别高血压患者中卒中风险较高的个体

Stroke：缺血性中风和精神病史患者在再灌注治疗和时间延迟方面的差异性

几乎四分之一的缺血性卒中患者有精神疾病史。无论精神疾病的严重程度如何，这些患者接受再灌注治疗的可能性较小。